$76MARPA-H; 10 programs
Every Cure's AI ranks 75 million drug–disease pairs; its patient wins so far came from clinicians or predate the window.
The nonprofit reviewed 9,000+ repurposing opportunities in 2025 and has ten active programs; the AI-identified adalimumab–Castleman case (NEJM) was February 2025, and the DFMO–Bachmann-Bupp program (six treated, five children improved) originated with the researchers who identified the disease.
What would change this
A documented patient outcome where the drug–disease match originated from the MATRIX platform, with dates.
Sources
- primaryEvery Cure: up to $76M from ARPA-Heverycure.org
- secondaryCNBC: Every Cure's drug repurposing strategycnbc.com
History
- Added.
Cite this entry
Permalink https://becauseofai.org/entry/every-cure-repurposing
“Every Cure's AI ranks 75 million drug–disease pairs; its patient wins so far came from clinicians or predate the window.” Because of AI, updated Oct 22, 2026. https://becauseofai.org/entry/every-cure-repurposing@misc{becauseofai_every_cure_repurposing,
title = {Every Cure's AI ranks 75 million drug–disease pairs; its patient wins so far came from clinicians or predate the window.},
howpublished = {\url{https://becauseofai.org/entry/every-cure-repurposing}},
note = {Because of AI registry, updated Oct 22, 2026},
year = {2026}
}